Multidimensional Proteomics Analysis of Amniotic Fluid to Provide Insight into the Mechanisms of Idiopathic Preterm Birth
暂无分享,去创建一个
C. Buhimschi | I. Buhimschi | Guomao Zhao | S. Thung | V. Rosenberg | S. Abdel-Razeq | Victor A. Rosenberg | G. Zhao
[1] J. Martin,et al. Births: final data for 2005. , 2007, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[2] György Marko-Varga,et al. Personalized medicine and proteomics: lessons from non-small cell lung cancer. , 2007, Journal of proteome research.
[3] Leonardo Pereira,et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. , 2007, Journal of proteome research.
[4] V. Bhandari,et al. Proteomic Biomarkers of Intra-amniotic Inflammation: Relationship with Funisitis and Early-onset Sepsis in the Premature Neonate , 2007, Pediatric Research.
[5] V. Bhandari,et al. Proteomic Profiling of the Amniotic Fluid to Detect Inflammation, Infection, and Neonatal Sepsis , 2007, PLoS medicine.
[6] Nan Guo,et al. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways , 2006, Nucleic Acids Res..
[7] M. Purwar,et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. , 2006, Bulletin of the World Health Organization.
[8] C. Weiner,et al. Clinical Proteomics: A Novel Diagnostic Tool for the New Biology of Preterm Labor, Part I: Proteomics Tools , 2006, Obstetrical & gynecological survey.
[9] C. Weiner,et al. Proteomic biomarkers that predict the clinical success of rescue cerclage. , 2005, American journal of obstetrics and gynecology.
[10] C. Buhimschi,et al. Proteomic biomarker analysis of amniotic fluid for identification of intra‐amniotic inflammation , 2005, BJOG : an international journal of obstetrics and gynaecology.
[11] B. Vohr,et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.
[12] H. Matsuzaki,et al. Bikunin Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Induction in Macrophages , 2004, Clinical Diagnostic Laboratory Immunology.
[13] N. Vij,et al. Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. , 2004, Experimental eye research.
[14] J. Martin,et al. Births: final data for 2002. , 2003, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[15] C. Lockwood. Testing for risk of preterm delivery. , 2003, Clinics in laboratory medicine.
[16] J. Moutquin. Classification and heterogeneity of preterm birth , 2003, BJOG : an international journal of obstetrics and gynaecology.
[17] M. Suzuki,et al. The Protease Inhibitor Bikunin, a Novel Anti-Metastatic Agent , 2003, Biological chemistry.
[18] K. Volz,et al. Pigment Epithelium-Derived Factor (PEDF), a Serpin with Potent Anti-Angiogenic and Neurite Outgrowth-promoting Properties , 2002, Biological chemistry.
[19] Emanuel F. Petricoin,et al. Clinical Applications of Proteomics: Proteomic Pattern Diagnostics , 2002, Journal of Mammary Gland Biology and Neoplasia.
[20] L. Giudice,et al. Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. , 2001, The Journal of clinical endocrinology and metabolism.
[21] Stark Ar. 超出生体重児に対する早期デキサメサゾン投与の有用性 : National Institute of Child Health and Human Development Neonatal research Network報告 (海外誌掲載論文の和文概要とそれに対するコメント) , 2001 .
[22] D. Sherer,et al. Chronic Intrauterine Bleeding and Fetal Growth at Less than 32 Weeks of Gestation , 2000, Gynecologic and Obstetric Investigation.
[23] A. Blom,et al. Bikunin--not just a plasma proteinase inhibitor. , 2000, The international journal of biochemistry & cell biology.
[24] H. Kobayashi,et al. Urinary trypsin inhibitor down-regulates hyaluronic acid fragment-induced prostanoid release in cultured human amnion cells by inhibiting cyclo-oxygenase-2 expression. , 1999, Molecular human reproduction.
[25] Terry Magnuson,et al. Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.
[26] P. Giraudet,et al. Insulin-Like Growth Factor Binding Protein 1 Level in Amniotic Fluid: Correlation with Birth Weight , 1998, Neonatology.
[27] D. Clemmons,et al. The secretion of insulin-like growth factor I, prolactin and insulin-like growth factor binding protein 1 by the decidua as predictors of human fetal growth. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[28] Y. Futamura,et al. Role of Urinary Trypsin Inhibitor in the Maintenance of Pregnancy in Mice , 1996, Obstetrics and gynecology.
[29] T. Terao,et al. Urinary trypsin inhibitor prevents uterine muscle contraction by inhibition of Ca++ influx. , 1995, American journal of obstetrics and gynecology.
[30] T. Terao,et al. Urinary trypsin inhibitor suppresses premature cervical ripening. , 1995, European journal of obstetrics, gynecology, and reproductive biology.
[31] R. Knuppel,et al. Amniotic fluid α1-antitrypsin concentration in premature rupture of the membranes , 1990 .
[32] L. Silberman,et al. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies , 1989, Obstetrics and gynecology.
[33] M. T. Brewer,et al. Cloning, characterization, and expression of a human insulin-like growth factor binding protein. , 1988, Biochemical and biophysical research communications.
[34] T. Terao,et al. The relationship between trypsin activity in amniotic fluid and premature rupture of membranes. , 1986, American Journal of Obstetrics and Gynecology.
[35] Kerstin,et al. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. , 1986, The Journal of biological chemistry.
[36] Alexey I Nesvizhskii,et al. Protein identification by tandem mass spectrometry and sequence database searching. , 2007, Methods in molecular biology.
[37] ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. , 2007, Obstetrics and gynecology.
[38] J. Chambaz,et al. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV. , 2000, International journal of tissue reactions.
[39] Rick W. Martin,et al. Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. , 1998, American journal of obstetrics and gynecology.
[40] T. Terao,et al. Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries. , 1996, Gynecologic and Obstetric Investigation.
[41] R. Leboeuf,et al. Regulation by nutritional status of lipids and apolipoproteins A-I, A-II, and A-IV in inbred mice. , 1994, Journal of lipid research.
[42] R. Knuppel,et al. Amniotic fluid alpha 1-antitrypsin concentration in premature rupture of the membranes. , 1990, American Journal of Obstetrics and Gynecology.
[43] J. Fruchart,et al. Apolipoproteins in human amniotic fluid: concentrations, isoforms and polymorphism. , 1989, Gynecologic and Obstetric Investigation.
[44] W. Mckeehan,et al. Isolation of two proteinase inhibitors from human hepatoma cells that stimulate human endothelial cell growth. , 1987, Methods in Enzymology.
[45] E. Wachter,et al. Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, IV. The amino acid sequence of the human urinary trypsin inhibitor isolated by affinity chromatography. , 1981, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.